TY - JOUR
T1 - Hypoglycemia and hyperglycemia in extremely low-birth-weight infants
AU - De Carolis, Maria Pia
AU - Rubortone, Serena Antonia
AU - Cocca, Carmen
AU - Pinna, Giovanni
AU - Tiberi, Eloisa
AU - Zecca, Enrico
AU - Romagnoli, Costantino
AU - Salvi, Silvia
AU - De Carolis, Sara
PY - 2015
Y1 - 2015
N2 - Background
Glucose metabolism disorders are common in extremely low birth weight (ELBW) infants and are associated with high morbidity and mortality [1-9]. This study was conducted to evaluate the prevalence and risk factors associated with both hypo and hyperglycemia in ELBW infants. Materials and methods
All inborn ELBW neonates admitted to our NICU during
a 5-year period were eligible for this retrospective
analysis. Exclusion criteria were: birth weight (BW) <400
grams, major congenital malformations, death during
the first 24 hours of life. Hypoglycemia was defined as
blood glucose level (BGL) ≤45 mg/dL; hyperglycemia as
BGL>240 mg/dL in a single determination or >180 mg/dL
in two determinations at 2-hour intervals. Continuous
intravenous insulin infusion was started after an ineffective
glucose restriction.
Results
Of 195 ELBW infants, 29 (14.8%) were excluded and
166 (GA 26.7 2.1 weeks, BW 751 152 grams) were analyzed
and grouped to their BGL. Normoglycemia was
observed in 79 neonates (47.6%) (N-Group); 80 neonates
(52.4%) showed abnormal BGL: 21 (12.7%) were hypoglycemic
(Hypo-Group), 53 (31.9%) hyperglycemic
(Hyper-Group) and 13 (7.8%) showed both hypoglycemia
and hyperglycemia (Hypo&Hyper-Group). Clinical
characteristics of the groups are reported in Table 1.
Hypo-Group respect to N-Group showed a higher rate
of small for gestational age (SGA) neonates (p=0.03).
Hyper-Group in comparison to N-Group showed a tendency
toward a lower GA (p=0.05), lower BW (p<0.001),
higher sepsis rate (p<0.001), higher rate of treatment
with inotropic agents (p=0.02), corticosteroids (p=0.006)
and nonsteroidal antiinflammatory drugs (p=0.01).
Hypo&Hyper-Group respect to N-Group showed similar
GA, lower BW (p<0.001), higher sepsis rate (p<0.01),
higher rate of inotropic treatment (p=0.04). Insulin was
administered in 35 neonates (66%) of Hyper-Group and
in 8 neonates (61.5%) of Hypo&Hyper-Group. Intraventricular
Hemorrhage ( IVH) rate was higher in HyperGroup
and Hypo&Hyper-Group respect to N-Group
(p=0.002) as well as IVH grade3 (p=0.001 and p=0.02,
respectively).The rate of both Retinopathy of Prematurity
( ROP) and ROP ≥stage 2 in survived neonates was
higher in Hyper-Group respect to N-Group (p=0.008
and p=0.002, respectively). Mortality was similar among
the groups (Table 2).
Conclusions
Among ELBW infants, hypoglycemia occurs more frequently
in SGA neonates, while hyperglycemia alone or
a marked variability of BGL (hypo and hyperglycaemia)
is more common in sick neonates. High rate of glucose
homeostasis disorders highlights the importance of carefully
monitoring BGL in order to a prompt management.
Continuous glucose monitoring recently used in
neonates [10] might be a useful tool for monitoring glucose
changes also in ELBW neonates.
AB - Background
Glucose metabolism disorders are common in extremely low birth weight (ELBW) infants and are associated with high morbidity and mortality [1-9]. This study was conducted to evaluate the prevalence and risk factors associated with both hypo and hyperglycemia in ELBW infants. Materials and methods
All inborn ELBW neonates admitted to our NICU during
a 5-year period were eligible for this retrospective
analysis. Exclusion criteria were: birth weight (BW) <400
grams, major congenital malformations, death during
the first 24 hours of life. Hypoglycemia was defined as
blood glucose level (BGL) ≤45 mg/dL; hyperglycemia as
BGL>240 mg/dL in a single determination or >180 mg/dL
in two determinations at 2-hour intervals. Continuous
intravenous insulin infusion was started after an ineffective
glucose restriction.
Results
Of 195 ELBW infants, 29 (14.8%) were excluded and
166 (GA 26.7 2.1 weeks, BW 751 152 grams) were analyzed
and grouped to their BGL. Normoglycemia was
observed in 79 neonates (47.6%) (N-Group); 80 neonates
(52.4%) showed abnormal BGL: 21 (12.7%) were hypoglycemic
(Hypo-Group), 53 (31.9%) hyperglycemic
(Hyper-Group) and 13 (7.8%) showed both hypoglycemia
and hyperglycemia (Hypo&Hyper-Group). Clinical
characteristics of the groups are reported in Table 1.
Hypo-Group respect to N-Group showed a higher rate
of small for gestational age (SGA) neonates (p=0.03).
Hyper-Group in comparison to N-Group showed a tendency
toward a lower GA (p=0.05), lower BW (p<0.001),
higher sepsis rate (p<0.001), higher rate of treatment
with inotropic agents (p=0.02), corticosteroids (p=0.006)
and nonsteroidal antiinflammatory drugs (p=0.01).
Hypo&Hyper-Group respect to N-Group showed similar
GA, lower BW (p<0.001), higher sepsis rate (p<0.01),
higher rate of inotropic treatment (p=0.04). Insulin was
administered in 35 neonates (66%) of Hyper-Group and
in 8 neonates (61.5%) of Hypo&Hyper-Group. Intraventricular
Hemorrhage ( IVH) rate was higher in HyperGroup
and Hypo&Hyper-Group respect to N-Group
(p=0.002) as well as IVH grade3 (p=0.001 and p=0.02,
respectively).The rate of both Retinopathy of Prematurity
( ROP) and ROP ≥stage 2 in survived neonates was
higher in Hyper-Group respect to N-Group (p=0.008
and p=0.002, respectively). Mortality was similar among
the groups (Table 2).
Conclusions
Among ELBW infants, hypoglycemia occurs more frequently
in SGA neonates, while hyperglycemia alone or
a marked variability of BGL (hypo and hyperglycaemia)
is more common in sick neonates. High rate of glucose
homeostasis disorders highlights the importance of carefully
monitoring BGL in order to a prompt management.
Continuous glucose monitoring recently used in
neonates [10] might be a useful tool for monitoring glucose
changes also in ELBW neonates.
KW - Hypoglycemia, hyperglycemia, extremely low-birth-weight infants
KW - Hypoglycemia, hyperglycemia, extremely low-birth-weight infants
UR - http://hdl.handle.net/10807/94548
M3 - Article
SN - 1720-8424
SP - 1
EP - 2
JO - THE ITALIAN JOURNAL OF PEDIATRICS
JF - THE ITALIAN JOURNAL OF PEDIATRICS
ER -